Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Bacteriol ; 191(8): 2474-84, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19251856

RESUMEN

Francisella tularensis contains several highly pathogenic subspecies, including Francisella tularensis subsp. holarctica, whose distribution is circumpolar in the northern hemisphere. The phylogeography of these subspecies and their subclades was examined using whole-genome single nucleotide polymorphism (SNP) analysis, high-density microarray SNP genotyping, and real-time-PCR-based canonical SNP (canSNP) assays. Almost 30,000 SNPs were identified among 13 whole genomes for phylogenetic analysis. We selected 1,655 SNPs to genotype 95 isolates on a high-density microarray platform. Finally, 23 clade- and subclade-specific canSNPs were identified and used to genotype 496 isolates to establish global geographic genetic patterns. We confirm previous findings concerning the four subspecies and two Francisella tularensis subsp. tularensis subpopulations and identify additional structure within these groups. We identify 11 subclades within F. tularensis subsp. holarctica, including a new, genetically distinct subclade that appears intermediate between Japanese F. tularensis subsp. holarctica isolates and the common F. tularensis subsp. holarctica isolates associated with the radiation event (the B radiation) wherein this subspecies spread throughout the northern hemisphere. Phylogenetic analyses suggest a North American origin for this B-radiation clade and multiple dispersal events between North America and Eurasia. These findings indicate a complex transmission history for F. tularensis subsp. holarctica.


Asunto(s)
ADN Bacteriano/genética , Francisella tularensis/clasificación , Francisella tularensis/aislamiento & purificación , Geografía , Polimorfismo de Nucleótido Simple , Tularemia/epidemiología , Tularemia/microbiología , Asia/epidemiología , Técnicas de Tipificación Bacteriana , Análisis por Conglomerados , Europa (Continente)/epidemiología , Francisella tularensis/genética , Genoma Bacteriano , Genotipo , Análisis por Micromatrices/métodos , Epidemiología Molecular , América del Norte/epidemiología , Filogenia
2.
PLoS One ; 10(5): e0126626, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25970423

RESUMEN

Undetected and untreated, low-levels of drug resistant (DR) subpopulations in clinical Mycobacterium tuberculosis (Mtb) infections may lead to development of DR-tuberculosis, potentially resulting in treatment failure. Current phenotypic DR susceptibility testing has a theoretical potential for 1% sensitivity, is not quantitative, and requires several weeks to complete. The use of "single molecule-overlapping reads" (SMOR) analysis with next generation DNA sequencing for determination of ultra-rare target alleles in complex mixtures provides increased sensitivity over standard DNA sequencing. Ligation free amplicon sequencing with SMOR analysis enables the detection of resistant allele subpopulations at ≥0.1% of the total Mtb population in near real-time analysis. We describe the method using standardized mixtures of DNA from resistant and susceptible Mtb isolates and the assay's performance for detecting ultra-rare DR subpopulations in DNA extracted directly from clinical sputum samples. SMOR analysis enables rapid near real-time detection and tracking of previously undetectable DR sub-populations in clinical samples allowing for the evaluation of the clinical relevance of low-level DR subpopulations. This will provide insights into interventions aimed at suppressing minor DR subpopulations before they become clinically significant.


Asunto(s)
Antituberculosos/farmacología , Farmacorresistencia Bacteriana Múltiple/genética , Mycobacterium tuberculosis/genética , Tuberculosis Resistente a Múltiples Medicamentos/microbiología , Tuberculosis Pulmonar/microbiología , Antituberculosos/uso terapéutico , ADN Bacteriano/genética , ADN Bacteriano/aislamiento & purificación , Frecuencia de los Genes , Sitios Genéticos , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Pruebas de Sensibilidad Microbiana , Técnicas de Diagnóstico Molecular , Polimorfismo de Nucleótido Simple , Análisis de Secuencia de ADN , Esputo/microbiología , Tuberculosis Resistente a Múltiples Medicamentos/diagnóstico , Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico , Tuberculosis Pulmonar/diagnóstico , Tuberculosis Pulmonar/tratamiento farmacológico
3.
PLoS One ; 7(3): e32866, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22438886

RESUMEN

Single nucleotide polymorphisms (SNPs) are abundant in genomes of all species and biologically informative markers extensively used across broad scientific disciplines. Newly identified SNP markers are publicly available at an ever-increasing rate due to advancements in sequencing technologies. Efficient, cost-effective SNP genotyping methods to screen sample populations are in great demand in well-equipped laboratories, but also in developing world situations. Dual Probe TaqMan assays are robust but can be cost-prohibitive and require specialized equipment. The Mismatch Amplification Mutation Assay, coupled with melt analysis (Melt-MAMA), is flexible, efficient and cost-effective. However, Melt-MAMA traditionally suffers from high rates of assay design failures and knowledge gaps on assay robustness and sensitivity. In this study, we identified strategies that improved the success of Melt-MAMA. We examined the performance of 185 Melt-MAMAs across eight different pathogens using various optimization parameters. We evaluated the effects of genome size and %GC content on assay development. When used collectively, specific strategies markedly improved the rate of successful assays at the first design attempt from ~50% to ~80%. We observed that Melt-MAMA accurately genotypes across a broad DNA range (~100 ng to ~0.1 pg). Genomic size and %GC content influence the rate of successful assay design in an independent manner. Finally, we demonstrated the versatility of these assays by the creation of a duplex Melt-MAMA real-time PCR (two SNPs) and conversion to a size-based genotyping system, which uses agarose gel electrophoresis. Melt-MAMA is comparable to Dual Probe TaqMan assays in terms of design success rate and accuracy. Although sensitivity is less robust than Dual Probe TaqMan assays, Melt-MAMA is superior in terms of cost-effectiveness, speed of development and versatility. We detail the parameters most important for the successful application of Melt-MAMA, which should prove useful to the wider scientific community.


Asunto(s)
Bacterias/genética , Técnicas Bacteriológicas , Polimorfismo de Nucleótido Simple , Alelos , Bacterias/patogenicidad , Técnicas Bacteriológicas/economía , Composición de Base , Disparidad de Par Base , Secuencia de Bases , Análisis Costo-Beneficio , Análisis Mutacional de ADN , Cartilla de ADN/genética , ADN Bacteriano/química , ADN Bacteriano/genética , Genoma Bacteriano , Genotipo , Humanos , Modelos Genéticos , Técnicas de Amplificación de Ácido Nucleico , Desnaturalización de Ácido Nucleico , Reacción en Cadena en Tiempo Real de la Polimerasa
4.
Arch Otolaryngol Head Neck Surg ; 137(7): 664-8, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21768410

RESUMEN

OBJECTIVE: To characterize bacterial microbiota in middle ear, adenoid, and tonsil specimens using 16SrRNA gene-based pyrosequencing analysis. DESIGN: Cross-sectional study of bacterial microbiota in middle ear, adenoid, and tonsil specimens from a pediatric patient with chronic serous otitis media. Middle ear, adenoid, and tonsil specimens from a pediatric patient were collected and underwent cell lysis and DNA isolation. Pyrosequencing was performed on the 454 Life Sciences GS FLX platform (Roche Diagnostics Corp, Branford, Connecticut). Pyrosequencing data were processed, quality-checked, and taxonomically classified to generate an abundance-based matrix. Ecological analyses were performed. SETTING: Academic, tertiary referral center. MAIN OUTCOME MEASURES: Comparative microbiome analysis. RESULTS: We detected a total of 17 unique bacterial families, with 9, 9, and 12 bacterial families from the middle ear, tonsil, and adenoid specimens, respectively. Pseudomonadaceae dominated the middle ear microbiota at 82.7% relative abundance, whereas Streptococcaceae dominated the tonsil microbiota at 69.2%. Multiple bacteria, including Pseudomonadaceae, Streptococcaceae, Fusobacteriaceae, and Pasteurellaceae, dominated the adenoid microbiota. Overlap between the middle ear and the tonsil microbiota was minimal. In contrast, the adenoid microbiota encompassed bacteria detected from middle ear and tonsil. CONCLUSIONS: Bacterial community analysis using pyrosequencing analysis revealed diverse, previously unknown bacterial communities in a set of pediatric middle ear, tonsil, and adenoid specimens. Our findings suggest that the adenoid may be a source site for both the middle ear and tonsil microbiota. An ecological framework is appropriate in comparative analysis of microbiota from nonsterile body sites.


Asunto(s)
Oído Medio/microbiología , Metagenoma/genética , Otitis Media con Derrame/microbiología , ARN Ribosómico 16S/análisis , Análisis de Secuencia de ARN/métodos , Streptococcaceae/genética , Adenoidectomía , Tonsila Faríngea/microbiología , Tonsila Faríngea/cirugía , Niño , Enfermedad Crónica , Estudios Transversales , Oído Medio/cirugía , Humanos , Masculino , Otitis Media con Derrame/diagnóstico , Otitis Media con Derrame/genética , Procedimientos Quirúrgicos Otológicos/métodos , Tonsila Palatina/microbiología , Tonsila Palatina/cirugía , ARN Ribosómico 16S/genética , Streptococcaceae/aislamiento & purificación , Tonsilectomía
5.
BMC Res Notes ; 2: 223, 2009 Nov 06.
Artículo en Inglés | MEDLINE | ID: mdl-19895698

RESUMEN

BACKGROUND: Francisella tularensis is the etiologic agent of tularemia and is classified as a select agent by the Centers for Disease Control and Prevention. Currently four known subspecies of F. tularensis that differ in virulence and geographical distribution are recognized:tularensis (type A), holarctica (type B), mediasiatica, and novicida. Because of the Select Agent status and differences in virulence and geographical location, the molecular analysis of any clinical case of tularemia is of particular interest. We analyzed an unusual Francisella clinical isolate from a human infection in Arizona using multiple DNA-based approaches. FINDINGS: We report that the isolate is F. tularensis subsp. novicida, a subspecies that is rarely isolated. CONCLUSION: The rarity of this novicida subspecies in clinical settings makes each case study important for our understanding of its role in disease and its genetic relationship with other F. tularensis subspecies.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA